SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 244 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $209,000 | -2.3% | 5,758 | -4.4% | 0.01% | 0.0% |
| Q4 2022 | $214,000 | +4.9% | 6,021 | -0.4% | 0.01% | -11.1% |
| Q3 2022 | $204,000 | +1.5% | 6,045 | -3.2% | 0.01% | +28.6% |
| Q1 2022 | $201,000 | -38.2% | 6,242 | -47.2% | 0.01% | -36.4% |
| Q3 2019 | $325,000 | -24.4% | 11,815 | -9.1% | 0.01% | -21.4% |
| Q2 2019 | $430,000 | -4.0% | 12,991 | +1.7% | 0.01% | 0.0% |
| Q1 2019 | $448,000 | -33.0% | 12,779 | -36.6% | 0.01% | -39.1% |
| Q4 2018 | $669,000 | -42.4% | 20,144 | -12.7% | 0.02% | -30.3% |
| Q3 2018 | $1,162,000 | +129.2% | 23,086 | +172.5% | 0.03% | +43.5% |
| Q2 2018 | $507,000 | – | 8,471 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |